Patents by Inventor Refaat A. Hegazi

Refaat A. Hegazi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers
    Patent number: 10064835
    Abstract: Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: September 4, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Jeffrey L. Nelson, Anne C. Voss, Maria G. Baggs, Charles L. Paule, Refaat A. Hegazi, Fabrizis Suarez, Gary Fanjiang
  • COMBINATION OF BETA-HYDROXY-BETA-METHYLBUTYRATE, ARGININE AND GLUTAMINE FOR USE IN TREATING DIABETIC ULCERS
    Publication number: 20150133548
    Abstract: Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition.
    Type: Application
    Filed: January 10, 2013
    Publication date: May 14, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: Jeffrey L. Nelson, Anne C. Voss, Maria G. Baggs, Charles L. Paule, Refaat A. Hegazi, Fabrizis Suarez, Gary Fanjiang
  • Method and system for managing patient healthcare
    Patent number: 8930222
    Abstract: Methods and systems are provided for managing patient healthcare, which include creating a patient profile for a patient, screening and assessing the patient with respect to a disease and updating the patient profile, determining a health management status of the patient with respect to the disease based on a comparison of the updated patient profile to at least one predefined criterion regarding progression of the disease, and providing a recommended action based upon the health management status and updated patient profile.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: January 6, 2015
    Assignee: Abbott Laboratories
    Inventors: Amy L. Rhine-Pallas, Robert J. Padley, Brett M. Hickman, Clifford Bleustein, Refaat A. Hegazi, Sudarshan Hebbar, David K. Spindell, Paul Audhya
  • Method And System For Managing Patient Healthcare
    Publication number: 20120035958
    Abstract: Methods and systems are provided for managing patient healthcare, which include creating a patient profile for a patient, screening and assessing the patient with respect to a disease and updating the patient profile, determining a health management status of the patient with respect to the disease based on a comparison of the updated patient profile to at least one predefined criterion regarding progression of the disease, and providing a recommended action based upon the health management status and updated patient profile.
    Type: Application
    Filed: August 5, 2011
    Publication date: February 9, 2012
    Inventors: Amy L. Rhine-Pallas, Robert J. Padley, Brett M. Hickman, Clifford Bleustein, Refaat A. Hegazi, Sudarshan Hebbar, David K. Spindell, Paul Audhya